Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial

INTRODUCTION: Carnosine, an over the counter food supplement, has been shown to improve glucose metabolism as well as cardiovascular risk factors in animal and human studies through its anti-inflammatory, antioxidative, antiglycating and chelating properties. The aim of this study is to establish if...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Menon, Kirthi, Cameron, James D, de Courten, Maximilian, de Courten, Barbora
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2021
Gaiak:
Public Health
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126302/
https://ncbi.nlm.nih.gov/pubmed/33986049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-043680
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak